Validation of low-dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over-the-counter use?

Apr-16

AUTHORS : Dr Luis A. Garcia Rodríguez, Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Almirante 28, 28004 Madrid, Spain – Email: lagarcia@ceife.es – Profile: http://www.ceife.es/quienes-somos.html

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 25(4):392-8

DOI : 10.1002/pds.3926

Validation of low-dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over-the-counter use?

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study